Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
4.640
-0.090 (-1.90%)
At close: Feb 10, 2026, 4:00 PM EST
4.730
+0.090 (1.94%)
After-hours: Feb 10, 2026, 6:32 PM EST
Nyxoah Revenue
Nyxoah had revenue of 1.97M EUR in the quarter ending September 30, 2025, with 55.77% growth. This brings the company's revenue in the last twelve months to 5.64M, up 10.96% year-over-year. In the year 2024, Nyxoah had annual revenue of 4.52M with 3.98% growth.
Revenue (ttm)
5.64M EUR
Revenue Growth
+10.96%
P/S Ratio
30.80
Revenue / Employee
30,714 EUR
Employees
184
Market Cap
203.79M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.52M | 173.00K | 3.98% |
| Dec 31, 2023 | 4.35M | 1.26M | 40.99% |
| Dec 31, 2022 | 3.08M | 2.23M | 261.97% |
| Dec 31, 2021 | 852.00K | 783.00K | 1,134.78% |
| Dec 31, 2020 | 69.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AngioDynamics | 307.31M |
| OraSure Technologies | 125.70M |
| Sanara MedTech | 101.88M |
| Pro-Dex | 72.10M |
| KORU Medical Systems | 39.07M |
| Utah Medical Products | 38.52M |
| Stereotaxis | 30.08M |
| Anteris Technologies Global | 2.14M |
NYXH News
- 20 days ago - Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewsWire
- 21 days ago - Nyxoah SA (NYXH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Publication relating to transparency notification - GlobeNewsWire
- 7 weeks ago - Nyxoah Announces Issuance of First Tranche of Convertible Bonds - GlobeNewsWire
- 2 months ago - Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands - GlobeNewsWire
- 2 months ago - Publication relating to transparency notifications - GlobeNewsWire
- 2 months ago - Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 2 months ago - Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule - GlobeNewsWire